News

Revolutionary hemostatic gel for veterinary surgeons now available through Covetrus, MWI Animal Health, and Patterson Veterinary Supply   NEW YORK (April 19, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for its revolutionary hemostatic gel, VETIGEL®, to be sold directly […]

Original news piece from Fast Company Cresilon’s hemostatic gel that can help blood clot without pressure has made it one of the most innovative medical device companies of 2024. Every year, about 1.5 million people worldwide die from blood loss. The problem is especially acute when the loss is caused by trauma, which has no

Aug 9, 2022 Joe Landolina is the CEO and Co-Founder of Cresilon, the only fill-and-finish operation in the five boroughs of New York. Building on a discovery about the ability to stop all kinds of bleeding, Cresilon is using recycled algae, meaning algae or kelp that has washed up onto the shoreline. The vendors they

Catastrophic bleeding is a cause of death after a wide variety of wounds in humans and other animals. This week’s podcast speaks with Joe Landolina from Cresilon, describing natural polymers that immediately cease bleeding, along with their military, medical and veterinary applications. by Dr. Kevin Folta in Talking Biotech A significant number of fatalities are

Posted in DDW Exclusive Content When he was 17 years old, Joe Landolina created a revolutionary gel. Now, he is 29 years old and co-founder and CEO of Cresilon, his homegrown Brooklyn-based biotech company that recently submitted the gel for FDA 510(k) clearance for human use and raised $38.5 million in Series A3 financing last